Clear Harbor Asset Management, LLC Bei Gene, Ltd. Transaction History
Clear Harbor Asset Management, LLC
- $1.13 Billion
- Q1 2024
A detailed history of Clear Harbor Asset Management, LLC transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Clear Harbor Asset Management, LLC holds 1,571 shares of BGNE stock, worth $224,134. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,571
Previous 1,155
36.02%
Holding current value
$224,134
Previous $208,000
17.79%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding BGNE
# of Institutions
216Shares Held
45.1MCall Options Held
76.5KPut Options Held
72.3K-
Baker Bros. Advisors LP New York, NY10.6MShares$1.51 Billion20.93% of portfolio
-
Capital International Investors Los Angeles, CA7.06MShares$1.01 Billion0.23% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.18MShares$739 Million17.98% of portfolio
-
Primecap Management CO Pasadena, CA5MShares$714 Million0.59% of portfolio
-
Baillie Gifford & CO3.73MShares$532 Million0.46% of portfolio
About BeiGene, Ltd.
- Ticker BGNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,700,000
- Market Cap $14.8B
- Description
- BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...